Health

JUNG KWAN JANG Launches Black Friday & Holiday Promotions and Introduces New Wellness Innovations for U.S. Consumers

* Global wellness brand JUNG KWAN JANG rolls out major Black Friday and holiday-season promotions across the U.S. * New products including EVERYTIME and Hong Sam Won gain momentum on Amazon, Costco, and other major retail channels * Korean Red Ginseng rises worldwide as a leading natural, n...

2025-11-25 21:00 747

Mazdutide 9mg Supplementary Application Accepted for Review by China's NMPA, Potentially Offering a Novel Drug Option for Moderate-to-Severe Obese Population

SAN FRANCISCO and SUZHOU, China, Nov. 25, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metaboli...

2025-11-25 17:00 858

HKeyBio Launches the HKEY-AIDMD 3.0--a Next-Generation Platform to Crack the Toughest Challenge in Autoimmune and Allergy Drug Development: Multi-target Combination Strategy Optimization

* The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBio has established four-dimensional (4D) model pools that simulate clinical heterogeneity, providing a mechanism-driven model selection platf...

2025-11-25 00:30 1140

ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

* Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology * Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- ToolGen Inc. (K...

2025-11-24 22:00 1018

Pinnacle Food Announces New Strategic Initiative to Expand its Smart Agriculture Innovation Platform

VANCOUVER, BC, Nov. 24, 2025 /PRNewswire/ -- Pinnacle Food Group Limited (NASDAQ:PFAI) announced a strategic initiative to establish a bioengineering and testing laboratory. The Company is exploring applied bioengineering initiatives to further expand its smart agriculture innovation platform int...

2025-11-24 21:00 748

HoneyNaps Accelerates Clinical Trial Pipelines with FDA-Cleared AI "SOMNUM"

* Enhancing Clinical Efficiency with AI Sleep Analysis: Cutting Both Cost and Time * Joint Clinical Studies with CROs: SOMNUM™ AI Sleep Scoring Drives Higher Efficiency * FDA-cleared AI solution shortens clinical trial timelines while ensuring data reliability * Expanded global partnershi...

2025-11-24 17:24 610

Pin Therapeutics Initiates First-Patient Dosing of CK1α Degrader PIN-5018 in Phase 1 Trial

Preclinical Results Demonstrate Complete Response and Tumor Regression in ACC PDX Models SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced onNovember 20 that it has administered the f...

2025-11-24 15:11 743

Harbour BioMed Advances Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Biotherapeutics in Oncology

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 23, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics for immunology and oncology, today announced an u...

2025-11-24 08:01 1117

Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up

PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum London 2025 in the UK. This marks the Forum's second edition inEurope and the eighth consecutive G...

2025-11-22 06:32 2084

BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC

* Celebrating a Shared Milestone: BioDlink and Lepu Biopharma celebrated the launch of MEIYOUHENG®, the world's first EGFR-Targeting ADC, and their partnership spanning over two years. * Demonstrating Robust Capabilities: Throughout the collaboration, all technology transfers and GMP manufact...

2025-11-21 21:00 1241

Dimora Medical Reaffirms Long-Term Commitment to Pressure Injury Patients on Worldwide Pressure Injury Prevention Day

NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Observed annually on the third Thursday of November each year, Worldwide Pressure Injury Prevention Day serves as a global reminder of the urgent need to prevent pressure injuries, also known as pressure ulcers or bedsores, among vulnerable populations. Est...

2025-11-21 11:14 621

HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases

* Company enters into new agreement with the Gates Foundation to identify novel drug leads targeting tuberculosis and malaria and new agents for non-hormonal contraception. CHENGDU, China, Nov. 20, 2025 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH...

2025-11-20 22:30 827

GENPRIME ACCELERATES GLOBAL GROWTH WITH FERTILITY CENTRE LAUNCHES IN SINGAPORE AND MANILA

The Singapore and New York-headquartered network of clinics expands its Southeast Asia presence, addressing global family-building challenges with technology and empathy NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Rhea Fertility, the reproductive health platform headquartered inSingapore and New Yor...

2025-11-20 22:00 826

ReviR Therapeutics Receives $4.6 Million CIRM Grant to Advance Huntington's Disease Treatment and Announces Key Development Milestone

BRISBANE, Calif., Nov. 20, 2025 /PRNewswire/ -- ReviR Therapeutics, a biotech company focused on developing innovative treatments for neurogenetic diseases, announced today that it has been awarded a$4.6M grant from the California Institute for Regenerative Medicine (CIRM)

2025-11-20 22:00 733

Gong Yingying: The Next Era of AI Healthcare Requires Trust, Real-World Scenarios, and Universal Accessibility

KUALA LUMPUR, Malaysia, Nov. 20, 2025 /PRNewswire/ -- At the 2025 Fortune Innovation Forum inKuala Lumpur, global industry leaders and innovators gathered to explore the technologies transforming healthcare. Speaking at the featured roundtable "AI vs. MD," Ms. Gong Yingying, Founder and Chairwoma...

2025-11-20 16:52 975

Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research

DURHAM, N.C. and SEOUL, South Korea, Nov. 20, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and comprehensive laboratory services, today announced a collaborative initiative to accelerate innovation i...

2025-11-20 13:01 1335

Dimora Medical Supports HS Connect Empower Workshop to Promote Science-Based Care for Hidradenitis Suppurativa Patients

NEW YORK, Nov. 19, 2025 /PRNewswire/ -- Patient-centered nonprofit organization HS Connect recently hosted the Empower HS: Knowledge and Advocacy Workshop, an educational event designed to help individuals living with Hidradenitis Suppurativa (HS) and their caregivers gain the knowledge and confi...

2025-11-20 01:48 979

BestQool Announces Up to 21% Off Red Light Therapy Devices on Amazon for Black Friday

NEW YORK, Nov. 19, 2025 /PRNewswire/ -- This Black Friday, BestQool invites everyone to pause, breathe, and take a moment for themselves. Even a brief daily red light therapy session ca...

2025-11-19 23:04 624

Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions

BEIJING and LISBON, Portugal, Nov. 19, 2025 /PRNewswire/ -- At PEGS Europe 2025, one of the industry's premier gatherings for innovation in protein and antibody engineering, Tsingke Biotech highlighted its latest acceleratedprotein and anti...

2025-11-19 22:17 842

Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery

Agreement includes license to Nona's fully human HCAb platform for preclinical antibody discovery CAMBRIDGE, Mass., Nov. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea to IN...

2025-11-19 20:08 584
12345 ... 311